Caroline Schmidt-Lucke

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. pmc Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome
    Caroline Schmidt-Lucke
    Charité Medical University Berlin, Campus Benjamin Franklin, Dept of Cardiology and Pulmology, Germany
    Vasc Health Risk Manag 3:221-8. 2007
  2. pmc Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol
    Caroline Schmidt-Lucke
    Department of Molecular Cardiology, Internal Medicine III, J W Goethe University, Frankfurt, Germany
    PLoS ONE 5:e13790. 2010
  3. doi request reprint Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy
    Caroline Schmidt-Lucke
    Department of Internal Medicine III, Johann W Goethe University Frankfurt, Germany
    Atherosclerosis 211:249-54. 2010
  4. doi request reprint Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection
    Caroline Schmidt-Lucke
    Department of Cardiology and Pneumology, Charite University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany
    J Infect Dis 201:936-45. 2010
  5. ncbi request reprint Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy
    Stephan Fichtlscherer
    Department of Internal Medicine III, Division of Cardiology, Johann W Goethe University Frankfurt, Theodor Stern Kai 7, D 60590 Frankfurt, Germany
    Eur Heart J 27:1182-90. 2006
  6. ncbi request reprint Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair
    Caroline Schmidt-Lucke
    Molecular Cardiology, Department of Medicine III, J W Goethe University, Frankfurt, Germany
    Circulation 111:2981-7. 2005
  7. ncbi request reprint Specific recruitment of CD4+CD25++ regulatory T cells into the allograft in heart transplant recipients
    Caroline Schmidt-Lucke
    Department of Internal Medicine III, Division of Cardiology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    Am J Physiol Heart Circ Physiol 292:H2425-31. 2007
  8. doi request reprint Transactivation of human parvovirus B19 gene expression in endothelial cells by adenoviral helper functions
    Tanja Pozzuto
    Department of Cardiology and Pneumology, Campus Benjamin Franklin, Charite University Medicine Berlin, Hindenburgdamm 30, 12200 Berlin, Germany
    Virology 411:50-64. 2011
  9. ncbi request reprint Economic evaluation of enoxaparin for anticoagulation in early cardioversion of persisting nonvalvular atrial fibrillation: a statutory health insurance perspective from Germany
    Peter K Schädlich
    InForMed GmbH Outcomes Research and Health Economics, Ingolstadt, Germany
    Am J Cardiovasc Drugs 7:199-217. 2007
  10. ncbi request reprint Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (AC
    Caroline Schmidt-Lucke
    Molecular Cardiology, JW Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    Thromb Res 119:27-34. 2007

Detail Information

Publications12

  1. pmc Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome
    Caroline Schmidt-Lucke
    Charité Medical University Berlin, Campus Benjamin Franklin, Dept of Cardiology and Pulmology, Germany
    Vasc Health Risk Manag 3:221-8. 2007
    ..We review the studies of enoxaparin and discuss its current role in the contemporary treatment of NSTE-ACS...
  2. pmc Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol
    Caroline Schmidt-Lucke
    Department of Molecular Cardiology, Internal Medicine III, J W Goethe University, Frankfurt, Germany
    PLoS ONE 5:e13790. 2010
    ..We, therefore developed a novel protocol adapted from the standardised so-called ISHAGE protocol for enumeration of haematopoietic stem cells to enable comparison of clinical and laboratory data...
  3. doi request reprint Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy
    Caroline Schmidt-Lucke
    Department of Internal Medicine III, Johann W Goethe University Frankfurt, Germany
    Atherosclerosis 211:249-54. 2010
    ..The availability of ezetimibe, a potent novel cholesterol absorption inhibitor, allows to distinguish between lipid-lowering and pleiotropic properties of statins...
  4. doi request reprint Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection
    Caroline Schmidt-Lucke
    Department of Cardiology and Pneumology, Charite University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany
    J Infect Dis 201:936-45. 2010
    ..In a phase 1 study, we investigated whether interferon beta reduced endothelial damage in patients with cardiac persistence of human parvovirus B19 (B19V) infection...
  5. ncbi request reprint Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy
    Stephan Fichtlscherer
    Department of Internal Medicine III, Division of Cardiology, Johann W Goethe University Frankfurt, Theodor Stern Kai 7, D 60590 Frankfurt, Germany
    Eur Heart J 27:1182-90. 2006
    ..The clinical availability of ezetimibe, a potent novel cholesterol absorption inhibitor, enables to differentiate lipid-lowering effects from potential non-lipid-lowering (pleiotropic) mechanisms of statins...
  6. ncbi request reprint Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair
    Caroline Schmidt-Lucke
    Molecular Cardiology, Department of Medicine III, J W Goethe University, Frankfurt, Germany
    Circulation 111:2981-7. 2005
    ..Circulating EPCs may thus provide an endogenous repair mechanism to counteract ongoing risk factor-induced endothelial injury and to replace dysfunctional endothelium...
  7. ncbi request reprint Specific recruitment of CD4+CD25++ regulatory T cells into the allograft in heart transplant recipients
    Caroline Schmidt-Lucke
    Department of Internal Medicine III, Division of Cardiology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    Am J Physiol Heart Circ Physiol 292:H2425-31. 2007
    ..Recruitment of T(reg) into the cardiac allograft during transcoronary passage may induce graft tolerance during subclinical inflammation potentially influencing allograft vasculopathy...
  8. doi request reprint Transactivation of human parvovirus B19 gene expression in endothelial cells by adenoviral helper functions
    Tanja Pozzuto
    Department of Cardiology and Pneumology, Campus Benjamin Franklin, Charite University Medicine Berlin, Hindenburgdamm 30, 12200 Berlin, Germany
    Virology 411:50-64. 2011
    ..Thus the almost complete block in B19V gene expression seen in endothelial cells can be abrogated by infection with other viruses...
  9. ncbi request reprint Economic evaluation of enoxaparin for anticoagulation in early cardioversion of persisting nonvalvular atrial fibrillation: a statutory health insurance perspective from Germany
    Peter K Schädlich
    InForMed GmbH Outcomes Research and Health Economics, Ingolstadt, Germany
    Am J Cardiovasc Drugs 7:199-217. 2007
    ....
  10. ncbi request reprint Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (AC
    Caroline Schmidt-Lucke
    Molecular Cardiology, JW Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    Thromb Res 119:27-34. 2007
    ..We analysed respective data from the ACE trial on the quality of conventional anticoagulation, where most participating centres chose the TEE-guided approach...
  11. ncbi request reprint Use of subcutaneous enoxaparin compared to intravenous heparin and oral phenprocoumon in the setting of cardioversion--the ACE study (Anticoagulation in Cardioversion using Enoxaparin)
    Christoph Stellbrink
    Rheinisch Westfälische Technische Hochschule Aachen
    Card Electrophysiol Rev 7:382-6. 2003
    ..This article summarizes the study rationale and design. The results will be published shortly...
  12. ncbi request reprint Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE)
    Christoph Stellbrink
    Medizinische Klinik I, Rheinisch Westfälische Technische Hochschule Aachen, Aachen, Germany
    Circulation 109:997-1003. 2004
    ..Low-molecular-weight heparins may reduce the risk of bleeding, may obviate the need for intravenous access, and do not require frequent anticoagulation monitoring...